Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
A double-blind, placebo-controlled trial of adding erythropoietin to intravenous methylprednisolone for the treatment of unilateral acute optic neuritis of unknown or demyelinative origin.
Pharmacogenomic update on multiple sclerosis: a focus on actual and new therapeutic strategies.
Designed Glucopeptides Mimetics of Myelin Protein Epitopes As Synthetic Probes for the Detection of Autoantibodies, Biomarkers of Multiple Sclerosis.
Neuromyelitis optica.
Neurobehavioral disorders.
Multiple sclerosis: Sodium channel blocker protects axons in MS models.
Central Neuropathic Pain Syndromes.
Relapsing and progressive forms of multiple sclerosis: insights from pathology.
Neurodegeneration in multiple sclerosis is a process separate from inflammation: Yes.
Advances in the management of MS symptoms: real-life evidence.
Sativex(®) and clinical-neurophysiological measures of spasticity in progressive multiple sclerosis.
Vitamin D in clinically isolated syndrome: evidence for possible neuroprotection.
Clinical efficacy, safety, and tolerability of fingolimod for the treatment of relapsing-remitting multiple sclerosis.
Concomitant analysis of arterial, venous, and CSF flows using phase-contrast MRI: a quantitative comparison between MS patients and healthy controls.
[Diagnosis of multiple sclerosis].
Induction of intestinal Th17 cells by segmented filamentous bacteria.
Accuracy of Postcontrast 3D Turbo Spin Echo MR Sequence for the Detection of Enhanced Inflammatory Lesions in Patients with Multiple Sclerosis.
The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Correction: Meta-Analysis of the Relationship between Multiple Sclerosis and Migraine.
Multiple sclerosis: Monotherapy rules.
Danish translation and psychometric testing of the Rivermead Mobility Index.
The cooling effect on proinflammatory cytokines interferon-gamma, tumor necrosis factor-alpha, and nitric oxide in patients with multiple sclerosis.
Theiler's murine encephalomyelitis virus induced phenotype switch of microglia in vitro.
In vivo MR imaging of intercellular adhesion molecule-1 expression in an animal model of multiple sclerosis.
Pages
« first
‹ previous
…
334
335
336
337
338
339
340
341
342
…
next ›
last »